BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17135384)

  • 1. Persistent amnesia as a sequel of olanzapine-induced neuroleptic malignant syndrome.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(4):552-3. PubMed ID: 17135384
    [No Abstract]   [Full Text] [Related]  

  • 2. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
    Kunz M; Gomes FA; Tramontina JF; Kapczinski F
    J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence of neuroleptic malignant syndrome with olanzapine treatment.
    Gheorghiu S; Knobler HY; Drumer D
    Am J Psychiatry; 1999 Nov; 156(11):1836. PubMed ID: 10553758
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.
    Ayyıldız H; Turan Ş; Gülcü D; Poyraz CA; Pehlivanoğlu E; Çullu F; Arıkan MK
    Eat Weight Disord; 2016 Jun; 21(2):309-11. PubMed ID: 26607823
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine induced neuroleptic malignant syndrome.
    Patra BN; Khandelwal SK; Sood M
    Indian J Pharmacol; 2013; 45(1):98-9. PubMed ID: 23543750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome.
    Tofler IT; Ahmed B
    J Clin Psychopharmacol; 2003 Dec; 23(6):672-4. PubMed ID: 14624203
    [No Abstract]   [Full Text] [Related]  

  • 7. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.
    Moreno JL; Palau Fayos JM; Díaz de Santiago A; García de Yébenes J
    J Huntingtons Dis; 2012; 1(1):31-2. PubMed ID: 25063189
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine-induced neuroleptic malignant syndrome in an adolescent.
    Matheson KM; Gray G
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):322-4. PubMed ID: 22897669
    [No Abstract]   [Full Text] [Related]  

  • 10. [The malignant neuroleptic syndrome].
    Pietzcker A
    Nervenarzt; 1988 Dec; 59(12):691-700. PubMed ID: 2905769
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome presenting with acute renal failure.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1074-5. PubMed ID: 18281139
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine treatment and neuroleptic malignant syndrome.
    Doan RJ; Callaghan WD
    Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome associated with olanzapine.
    Johnson V; Bruxner G
    Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone].
    López-Torres E; Cobo I; Lucena MI
    Actas Esp Psiquiatr; 2007; 35(2):145-6. PubMed ID: 17401786
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Neuroleptic Malignant Syndrome with Electroconvulsive Therapy in an Adolescent with Psychosis.
    Tanidir C; Aksoy S; Canbek O; Aras GF; Kilicoglu AG; Erdogan A
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):179-80. PubMed ID: 26886722
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychosis or atypical neuroleptic malignant syndrome in an adolescent?
    Groff K; Coffey BJ
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):529-32. PubMed ID: 18928418
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome associated with quetiapine.
    al-Waneen R
    Can J Psychiatry; 2000 Oct; 45(8):764-5. PubMed ID: 11086565
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.
    Trutia A; Bledowski J; Pandurangi A; Kahn DA
    J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole-related severe neuroleptic malignant syndrome with deep coma and organic brain changes in an antipsychotic-naive adolescent boy.
    Riala K; Lahti A; Anttila E; Räsänen P
    J Clin Psychopharmacol; 2013 Feb; 33(1):126-7. PubMed ID: 23288233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.